NEJM reports that DTC spend increased 330% between ’96-’05

In a critical Aug. 16 article on the impact of DTC advertising, The New England Journal of Medicine reported that spending on DTC pharmaceutical advertising increased by 330% between 1996 and 2005.

October 1, 2007

4:00 am

In a critical Aug. 16 article on the impact of DTC advertising, The New England Journal of Medicine reported that spending on DTC pharmaceutical advertising increased by 330% between 1996 and 2005, while the number of warning and untitled letters issued on ads fell from 142 in 1997 to 21 in 2006.

From the October 01, 2007 Issue of MM+M - Medical Marketing and Media

From Our Partners

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.

Partner Content

The new brand.com experience

How healthcare manufacturers can improve customer engagement, drive high-value activity and inform future strategy with conversational AI.